Histamine 2 blocker drugs – famotidine
Last updated on August 26, 2024
|
Generic name |
famotidine |
|---|---|
|
Strength |
20 mg and 40 mg |
| Form |
tablet |
|
Special Authority criteria |
Approval period |
|---|---|
|
Treatment failure on prescription dose of, or intolerance to, ranitidine |
Indefinite |
Practitioner Exemptions
- Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
- Pediatrics
- Pediatric cardiology
- Pediatric general surgery
Special notes
- Prescription dose of ranitidine for adults is considered to be 150 mg twice daily or 300 mg once daily
- Non-prescription use of famotidine is not eligible for PharmaCare coverage